Ardelyx (ARDX) Receivables (2013 - 2026)
Ardelyx (ARDX) posted Receivables of $82.8 million for Q1 2026, up 15.3% on a QoQ basis from $71.8 million in Q4 2025, and up 78.28% year-over-year from $46.5 million in Q1 2025.
Ardelyx (ARDX) Receivables (2013 - 2026) Analysis & Trends
Ardelyx's Receivables history runs 12 years deep, the most recent figure standing at $82.8 million for Q1 2026.
- Quarterly Receivables rose 78.28% year-over-year to $82.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.8 million (up 78.28% YoY) and the FY2025 annual result came in at $71.8 million, up 24.51% from the prior year.
- Receivables was $82.8 million for Q1 2026 at Ardelyx, up from $71.8 million in the prior quarter.
- Across five years, Receivables topped out at $82.8 million in Q1 2026 and bottomed at $4.4 million in Q1 2022.
- A 5-year average of $36.8 million and a median of $37.2 million in 2024 frame the typical range for Receivables.
- Peak annual rise in Receivables reached 1714.63% in 2022, while the deepest fall reached 24.02% in 2022.
- Ardelyx's Receivables stood at $7.7 million in 2022, then soared by 184.9% to $22.0 million in 2023, then jumped by 161.93% to $57.7 million in 2024, then advanced by 24.51% to $71.8 million in 2025, then increased by 15.3% to $82.8 million in 2026.
- Business Quant data shows ARDX's Receivables at $82.8 million in Q1 2026, $71.8 million in Q4 2025, and $76.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 82.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.84 Mn |
| Dec 31, 2025 | 71.85 Mn |
| Sep 30, 2025 | 76.61 Mn |
| Jun 30, 2025 | 62.55 Mn |
| Mar 31, 2025 | 46.47 Mn |
| Dec 31, 2024 | 57.71 Mn |
| Sep 30, 2024 | 53.20 Mn |
| Jun 30, 2024 | 37.24 Mn |
| Mar 31, 2024 | 28.16 Mn |
| Dec 31, 2023 | 22.03 Mn |
| Sep 30, 2023 | 43.26 Mn |
| Jun 30, 2023 | 9.11 Mn |
| Mar 31, 2023 | 12.12 Mn |
| Dec 31, 2022 | 7.73 Mn |
| Sep 30, 2022 | 5.21 Mn |
| Jun 30, 2022 | 5.62 Mn |
| Mar 31, 2022 | 4.39 Mn |
| Dec 31, 2021 | 502,000.00 |
| Sep 30, 2021 | 287,000.00 |
| Mar 31, 2021 | 5.78 Mn |